Found: 30
Select item for more details and to access through your institution.
Glucagon-like Peptide 1 Receptor Agonists and Asthma Exacerbations: Which Patients Benefit Most?
- Published in:
- Annals of the American Thoracic Society, 2024, v. 21, n. 11, p. 1496, doi. 10.1513/AnnalsATS.202309-836OC
- By:
- Publication type:
- Article
Estimating time to pregnancy from current durations in a cross‐sectional sample.
- Published in:
- Biostatistics, 2002, v. 3, n. 4, p. 565, doi. 10.1093/biostatistics/3.4.565
- By:
- Publication type:
- Article
Liraglutide and semaglutide: Pooled post hoc analysis to evaluate risk of dementia in patients with type 2 diabetes: Human/Human trials: Other.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042909
- By:
- Publication type:
- Article
DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality.
- Published in:
- Diabetologia, 2018, v. 61, n. 1, p. 58, doi. 10.1007/s00125-017-4422-0
- By:
- Publication type:
- Article
Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2).
- Published in:
- Diabetologia, 2018, v. 61, n. 1, p. 48, doi. 10.1007/s00125-017-4423-z
- By:
- Publication type:
- Article
Prototype of an evidence‐based tool to aid individualized treatment for type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 7, p. 1666, doi. 10.1111/dom.14381
- By:
- Publication type:
- Article
Development of a hypoglycaemia risk score to identify high‐risk individuals with advanced type 2 diabetes in DEVOTE.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2248, doi. 10.1111/dom.14208
- By:
- Publication type:
- Article
Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2241, doi. 10.1111/dom.14049
- By:
- Publication type:
- Article
Occupational risks for uveal melanoma results from a case-control study in nine European countries.
- Published in:
- Cancer Causes & Control, 2005, v. 16, n. 4, p. 437, doi. 10.1007/s10552-004-5029-6
- By:
- Publication type:
- Article
Event dependent sampling of recurrent events.
- Published in:
- Lifetime Data Analysis, 2010, v. 16, n. 4, p. 580, doi. 10.1007/s10985-010-9172-y
- By:
- Publication type:
- Article
Type 2 Diabetes Patients Reach Target Glycemic Control Faster Using IDegLira than Either Insulin Degludec or Liraglutide Given Alone.
- Published in:
- Clinical Drug Investigation, 2016, v. 36, n. 4, p. 293, doi. 10.1007/s40261-016-0376-0
- By:
- Publication type:
- Article
Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes: The SWITCH 2 Randomized Clinical Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Repeated events and total time on test.
- Published in:
- Statistics in Medicine, 2008, v. 27, n. 19, p. 3817, doi. 10.1002/sim.3270
- By:
- Publication type:
- Article
Non-parametric estimation and model checking procedures for marginal gap time distributions for recurrent events.
- Published in:
- Statistics in Medicine, 2007, v. 26, n. 30, p. 5394, doi. 10.1002/sim.3135
- By:
- Publication type:
- Article
Treatmentwith glucagon-like peptide-1 receptor agonists and incidence of dementia: Data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2022, v. 8, n. 1, p. 1, doi. 10.1002/trc2.12268
- By:
- Publication type:
- Article
Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 Severity.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 5, p. 1169, doi. 10.1007/s13300-024-01562-1
- By:
- Publication type:
- Article
IDegLira Versus Alternative Intensification Strategies in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin Therapy.
- Published in:
- Diabetes Therapy, 2015, v. 6, n. 4, p. 573, doi. 10.1007/s13300-015-0142-y
- By:
- Publication type:
- Article
Adherence to lithium in naturalistic settings: results from a nationwide pharmacoepidemiological study.
- Published in:
- Bipolar Disorders, 2007, v. 9, n. 7, p. 730, doi. 10.1111/j.1399-5618.2007.00405.x
- By:
- Publication type:
- Article
Do antidepressants precipitate youth suicide?
- Published in:
- European Child & Adolescent Psychiatry, 2006, v. 15, n. 4, p. 232, doi. 10.1007/s00787-006-0527-6
- By:
- Publication type:
- Article
Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Treatment with antiparkinson and antidepressant drugs: A register-based, pharmaco-epidemiological study.
- Published in:
- Movement Disorders, 2007, v. 22, n. 14, p. 2037, doi. 10.1002/mds.21472
- By:
- Publication type:
- Article
Use of antiparkinsonian drugs in Denmark: Results from a nationwide pharmacoepidemiological study.
- Published in:
- Movement Disorders, 2006, v. 21, n. 8, p. 1221, doi. 10.1002/mds.20907
- By:
- Publication type:
- Article
65-LB: Real-World Continuous Glucose Monitoring Data on Time-in-Range from a U.S. Population, 2015–2019.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-65-LB
- By:
- Publication type:
- Article
21-LB: Derived Time-in-Range Is Associated with MACE in T2D: Data from the DEVOTE Trial.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-21-LB
- By:
- Publication type:
- Article
2187-PUB: Identifying Risk Predictors for Gastrointestinal Adverse Events with Once-Weekly Semaglutide.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-2187-PUB
- By:
- Publication type:
- Article
2160-PUB: Development of an Evidence-Based Tool to Facilitate Individualized Treatment in the Clinic for Patients with Type 2 Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-2160-PUB
- By:
- Publication type:
- Article
15-LB: Diabetes Duration Did Not Moderate the Reduction in Severe Hypoglycemia Seen with Degludec vs. Glargine U100 in DEVOTE.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-15-LB
- By:
- Publication type:
- Article
89-LB: Low Level of Agreement in Evaluation of Continuous Glucose Monitoring Profiles.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-89-LB
- By:
- Publication type:
- Article
8-LB: Outcomes of Type 2 Diabetes (T2D) Clustering Replicated in the DEVOTE Trial.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-8-LB
- By:
- Publication type:
- Article
11-LB: Nonsevere Hypoglycemia Predicts Increased Risk of Subsequent Severe Events in Patients with Type 2 Diabetes.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-11-LB
- By:
- Publication type:
- Article